Interpace Biosciences IDXG Stock
Interpace Biosciences Price Chart
Interpace Biosciences IDXG Financial and Trading Overview
| Interpace Biosciences stock price | 0.65 USD |
| Previous Close | 1.2 USD |
| Open | 1.2 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 1.15 - 1.25 USD |
| 52 Week Range | 0.51 - 3.55 USD |
| Volume | 1.58K USD |
| Avg. Volume | 6.12K USD |
| Market Cap | 5.39M USD |
| Beta (5Y Monthly) | 0.722535 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.41 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11 USD |
IDXG Valuation Measures
| Enterprise Value | 61.75M USD |
| Trailing P/E | N/A |
| Forward P/E | -8.333333 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.15972443 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 1.83 |
| Enterprise Value/EBITDA | -1165.028 |
Trading Information
Interpace Biosciences Stock Price History
| Beta (5Y Monthly) | 0.722535 |
| 52-Week Change | -62.12% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.55 USD |
| 52 Week Low | 0.51 USD |
| 50-Day Moving Average | 1.6 USD |
| 200-Day Moving Average | 1.43 USD |
IDXG Share Statistics
| Avg. Volume (3 month) | 6.12K USD |
| Avg. Daily Volume (10-Days) | 10.73K USD |
| Shares Outstanding | 4.31M |
| Float | 3.22M |
| Short Ratio | 0.19 |
| % Held by Insiders | 29.26% |
| % Held by Institutions | 0% |
| Shares Short | 47.36K |
| Short % of Float | 1.17% |
| Short % of Shares Outstanding | 1.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -57.37% |
| Operating Margin (ttm) | -6.48% |
| Gross Margin | 57.94% |
| EBITDA Margin | -0.15% |
Management Effectiveness
| Return on Assets (ttm) | -5.043% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 33.74M USD |
| Revenue Per Share (ttm) | 7.92 USD |
| Quarterly Revenue Growth (yoy) | 24.00% |
| Gross Profit (ttm) | 18.23M USD |
| EBITDA | -53000 USD |
| Net Income Avi to Common (ttm) | -4300000 USD |
| Diluted EPS (ttm) | -0.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.6M USD |
| Total Cash Per Share (mrq) | 1.3 USD |
| Total Debt (mrq) | 15.62M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.901 |
| Book Value Per Share (mrq) | -14.505 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5305000 USD |
| Levered Free Cash Flow (ttm) | -348875 USD |
Profile of Interpace Biosciences
| Country | United States |
| State | NJ |
| City | Parsippany |
| Address | Morris Corporate Center 1 |
| ZIP | 07054 |
| Phone | 855-776-6419 |
| Website | https://www.interpace.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 94 |
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis and prognosis of pancreatic cancer; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited number of factors; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.
Q&A For Interpace Biosciences Stock
What is a current IDXG stock price?
Interpace Biosciences IDXG stock price today per share is 0.65 USD.
How to purchase Interpace Biosciences stock?
You can buy IDXG shares on the OTC Markets OTCQX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Interpace Biosciences?
The stock symbol or ticker of Interpace Biosciences is IDXG.
Which industry does the Interpace Biosciences company belong to?
The Interpace Biosciences industry is Diagnostics & Research.
How many shares does Interpace Biosciences have in circulation?
The max supply of Interpace Biosciences shares is 4.42M.
What is Interpace Biosciences Price to Earnings Ratio (PE Ratio)?
Interpace Biosciences PE Ratio is 1.58536580 now.
What was Interpace Biosciences earnings per share over the trailing 12 months (TTM)?
Interpace Biosciences EPS is 0.41 USD over the trailing 12 months.
Which sector does the Interpace Biosciences company belong to?
The Interpace Biosciences sector is Healthcare.
Interpace Biosciences IDXG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq Industrial INDS | 10941.11 USD — |
+0.63
|
— — | 10779.62 USD — | 10949.28 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 102.27 USD — |
+0.16
|
— — | 100.88 USD — | 102.35 USD — | — - | — — |
- {{ link.label }} {{link}}